<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04578730</url>
  </required_header>
  <id_info>
    <org_study_id>DIM-05682-006-INT</org_study_id>
    <nct_id>NCT04578730</nct_id>
  </id_info>
  <brief_title>aCute HemORrhoidal Disease evALuation International Study</brief_title>
  <acronym>CHORALIS</acronym>
  <official_title>A Prospective, Observational (Non-interventional), International Study to Assess Conservative Treatments Effectiveness in Acute Phase of Hemorrhoidal Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Servier Affaires Médicales</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Servier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to assess in real-life setting the effectiveness of&#xD;
      conservative treatments on signs, symptoms and quality of life in patients consulting for&#xD;
      hemorrhoids in acute phase of the disease&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 16, 2021</start_date>
  <completion_date type="Anticipated">April 2022</completion_date>
  <primary_completion_date type="Anticipated">April 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Global improvement</measure>
    <time_frame>Week 4</time_frame>
    <description>Measured by Patient Global Impression of Change (PGIC) scale, and time to improvement.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Signs and symptoms severity: pain, discomfort, bleeding, prolapse, swelling, itching, and soiling</measure>
    <time_frame>Week 4</time_frame>
    <description>Measured by VAS (Visual analogue scale) and questioning with 4 points rate</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Quality of Life</measure>
    <time_frame>Week 4</time_frame>
    <description>Measured by HEMO-FISS QoL</description>
  </primary_outcome>
  <enrollment type="Anticipated">4000</enrollment>
  <condition>Hemorrhoids</condition>
  <eligibility>
    <study_pop>
      <textblock>
        patients suffering from hemorrhoidal disease in the acute phase&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age ≥18 years old;&#xD;
&#xD;
          -  Patient consulting for symptomatic acute phase of hemorrhoidal disease&#xD;
&#xD;
          -  Confirmed diagnosis of hemorrhoidal disease&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient consulting for emergency not related to hemorrhoidal disease;&#xD;
&#xD;
          -  Patient currently taking any treatment for hemorrhoidal disease;&#xD;
&#xD;
          -  Any anorectal procedure or surgery planned during the study ;&#xD;
&#xD;
          -  Anorectal procedure or surgery performed or incomplete convalescence following&#xD;
             anorectal procedure/surgery;&#xD;
&#xD;
          -  Known present perianal sepsis, inflammatory bowel disease, colorectal malignancy,&#xD;
             pre-existing sphincter injury, diseases of the anal canal;&#xD;
&#xD;
          -  Pregnant or breastfeeding woman.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Valérie Lehner</last_name>
    <phone>(33)1 55 72 60 00</phone>
    <email>valerie.lehner@servier.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Servier Affaires Medicales</name>
      <address>
        <city>Suresnes</city>
        <zip>92284</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 15, 2020</study_first_submitted>
  <study_first_submitted_qc>October 1, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 8, 2020</study_first_posted>
  <last_update_submitted>September 22, 2021</last_update_submitted>
  <last_update_submitted_qc>September 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>observationnal</keyword>
  <keyword>QoL</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhoids</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

